View More Recent Stories

Aug 8, 2024 02:38AM Mirum Pharamceuticals (MIRM) PT Raised to $44 at Baird

Aug 7, 2024 05:01PM Mirum Pharmaceuticals, Inc. (MIRM) Misses Q2 EPS by 5c ; Offers Guidance

Jul 26, 2024 03:06PM Mirum Pharmaceuticals, Inc. (MIRM) August 40 and 45 calls active as share price up 6.5%

Jul 26, 2024 02:51PM Mirum Pharmaceuticals (MIRM) said approached by Sobi about a takeover - source

Jul 25, 2024 08:35AM Mirum Pharmaceuticals' (MIRM) LIVMARLI Now Approved for PFIC in Patients 12 Months and Older

Jul 9, 2024 05:43AM Mirum Pharamceuticals (MIRM) PT Raised to $69 at JMP Securities

Jul 8, 2024 12:33PM Stifel Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Jul 1, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Jun 18, 2024 06:43AM Mirum Pharamceuticals (MIRM) PT Raised to $66 at H.C. Wainwright

Jun 17, 2024 03:22PM Mirum Pharamceuticals (MIRM) PT Raised to $62 at Evercore ISI

Jun 17, 2024 03:00PM Mirum Pharamceuticals (MIRM) PT Raised to $64 at Citi

Jun 17, 2024 01:37PM Mirum Pharamceuticals (MIRM) PT Raised to $57 at Morgan Stanley

Jun 17, 2024 10:28AM Stifel Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Jun 17, 2024 09:06AM Mirum Pharamceuticals (MIRM) PT Raised to $39 at Baird

Jun 17, 2024 08:41AM Citi Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Jun 17, 2024 08:04AM Mirum Pharmaceuticals' (MIRM) Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies

View More Recent Stories